WEST CHESTER, Ohio–(HSMN NewsFeed)–AtriCure, Inc. (Nasdaq: ATRC ), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to completion and approval of a written sett…
Devices, Cardiology, Litigation
AtriCure, cardiac ablation, atrial fibrillation
Posts on ‘November 4th, 2009’
AtriCure Announces Tentative Settlement with the Department of Justice
Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
RICHMOND, Va., Nov. 4 (HSMN NewsFeed) — Filtrona Porous Technologies, manufacturer of custom fluid handling fiber and foam components for the medical device and healthcare industry, and a division of UK-based Filtrona plc (Pink Sheets: FLRAF ), has rece…
Devices, Wound Care
Filtrona Porous Technologies, MediSponge RBR, MediSponge
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Company advances 3rd internally found program into clinical studies CAMBRIDGE, Mass.–(HSMN NewsFeed)–Acceleron Pharmaceutical, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blo…
Biopharmaceuticals, Oncology
Acceleron Pharma, ACE-041, angiogenesis, TGF-β, TGF-beta

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.